Whether herbal eye drops help in management of dry eye syndrome ?
Phase 4
Not yet recruiting
- Conditions
- Patients with sign and symptoms of shuskakshipaaka (dry eye syndrome)
- Registration Number
- CTRI/2018/03/012530
- Lead Sponsor
- All india Institute of Ayurveda
- Brief Summary
This study is an open label double arm randomised clinical trial comparing the efficacy of Rajnidaaru eye drops (2drop in each eye)along with Rasayan Churna(3g BD) and alone for 42 days in patients of shuskakshipaaka (Dry eye syndrome) for 30 days.The trail will be conducted in All India institute of Ayurveda.The primary outcome measures will be reduction in th clinical features of dry eye syndrome and the secondary outcomes will be changes in quality of life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- 1.Patients of either sex aged up to18.
- 60 years. 2.Patients presenting with signs and symptoms of Dry eye syndrome. 3.Willing and able to participate in the study.
Exclusion Criteria
- 1.Age group less than 18 and more than 60 years.
- 2.Severe cases of dry eye syndrome with complications like perforated corneal ulcer, Uveitis, Glaucoma.
- 3.Allergic eye disease i.e. vernal keratoconjunctivitis, Giant papillary conjunctivitis.
- 4.Non specific topical beta blocker users.
- 5.Inflammatory conditions like acute conjunctivitis.
- 6.Patients on steroids, oral contraceptive pills, estrogen replacement therapy or any other medication such as antispasmodic drugs like Atropine that may adversely affect the outcome of the study.
- 7.Patients suffering from major systemic illness necessitating long term drug treatment i.e. Psycho-epileptic drug users.
- 8.H/o hypersensitivity to the trial drug or any of its ingredients.
- 9.Persistent Contact Lens Users.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in clinical features of dry eye syndrome The patients will be assesed at the end of the study
- Secondary Outcome Measures
Name Time Method Changes in the quality of life The patients will be assesed at the end of the study
Trial Locations
- Locations (1)
AIIA
🇮🇳West, DELHI, India
AIIA🇮🇳West, DELHI, IndiaDr Manjusha RajagopalaPrincipal investigator7600901848bhatrajma2008@gmail.com